Skip to content
Screener

MiniMed Group MMED EPS (Diluted)

EPS (Diluted) at other companies

Veradermics logo
VeradermicsMANE
-$1.32+93.3%
BK
BKBK
$2.24+41.8%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Schering-Plough logo
Schering-PloughSGP
-$0.69+82.6%
Dycom Industries logo
Dycom IndustriesDY
$3.00+43.5%
Target logo
TargetTGT
$1.71-24.7%

Other financials

Income statement

See full
Revenue$790.0M+15.0%
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%

Balance sheet

See full
Cash & equivalents$298.0M+2,609%
Total debt$53.0M-20.9%
Total equity$3.6B+8.4%
Total assets$4.6B+10.2%

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$5.17B+2.3%
Enterprise value$4.93B—
P/S1.9×—

Profitability

See full
Gross margin54.4%—
Operating margin-4.2%—
Net margin-11.9%—
FCF margin-12%—

Returns & leverage

See full
Return on equity-9.3%—
Debt / equity0×—
Current ratio1.6×—

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: MiniMed Group’s 10-Q, filed April 17, 2026. Open the filing →

Filed
Apr 17, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-025777

FAQ

What is MiniMed Group's EPS (diluted)?
MiniMed Group (MMED) reported EPS (diluted) of -$0.47 in Q1 2026.
How has MiniMed Group's EPS (diluted) changed year-over-year?
MiniMed Group's EPS (diluted) decreased by 1075.0% year-over-year, from -$0.04 to -$0.47.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about MiniMed Group's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude